FDA label
What is Testim used for?
Testim contains testosterone. The FDA-approved uses below are quoted from the Indications and Usage section of its DailyMed label.
Source: DailyMed SPL label file dated 2026-10-23. Publisher page
The FDA label says: “TESTIM is indicated for testosterone replacement therapy in adult males for conditions associated with a deficiency or absence of endogenous testosterone: Primary hypogonadism (congenital or acquired): testicular failure due to cryptorchidism, bilateral torsion, orchitis, vanishing testis syndrome, orchiectomy, Klinefelter's syndrome, chemotherapy, or toxic damage from alcohol or heavy metals. ...”
Run it in Rivvi
Which 2027 plans near you dropped or restricted Testim?
Tier changes and new prior auth, step therapy or quantity limits, plan by plan.
Free to start. Opens Rivvi, the AI workspace for healthcare teams.
Testim, gel
Indications and Usage, quoted from the label by Endo USA, Inc. (NDA021454). Cross-references to other label sections are left out.
TESTIM is indicated for testosterone replacement therapy in adult males for conditions associated with a deficiency or absence of endogenous testosterone:
- Primary hypogonadism (congenital or acquired): testicular failure due to cryptorchidism, bilateral torsion, orchitis, vanishing testis syndrome, orchiectomy, Klinefelter's syndrome, chemotherapy, or toxic damage from alcohol or heavy metals. These men usually have low serum testosterone concentrations and gonadotropins (follicle-stimulating hormone [FSH], luteinizing hormone [LH]) above the normal range.
- Hypogonadotropic hypogonadism (congenital or acquired): gonadotropin or luteinizing hormone-releasing hormone (LHRH) deficiency or pituitary-hypothalamic injury from tumors, trauma, or radiation. These men have low testosterone serum concentrations but have gonadotropins in the normal or low range.
Limitations of Use:
- Safety and efficacy of TESTIM in men with “age-related hypogonadism” (also referred to as “late-onset hypogonadism”) have not been established.
- Safety and efficacy of TESTIM in males less than 18 years old have not been established.
- Topical testosterone products may have different doses, strengths, or application instructions that may result in different systemic exposure.
Source: DailyMed label, set id 9f2aae1f-898d-4955-be31-678e0cf85395, version 29, effective July 15, 2025. NDC 66887-001, one of 1 listing for this product.
Questions
What is Testim used for?
The FDA label says: “TESTIM is indicated for testosterone replacement therapy in adult males for conditions associated with a deficiency or absence of endogenous testosterone: Primary hypogonadism (congenital or acquired): testicular failure due to cryptorchidism, bilateral torsion, orchitis, vanishing testis syndrome, orchiectomy, Klinefelter's syndrome, chemotherapy, or toxic damage from alcohol or heavy metals. ...”
What drug class is Testim?
FDA lists testosterone in the Androgen established pharmacologic class.
Does this page cover off-label uses or dosing?
No. This page shows only the Indications and Usage section of the FDA label. Ask a pharmacist or prescriber about dosing.
More on Testim
- Is Testim a controlled substance?Schedule III
- Generic for TestimFDA Orange Book
- What is Testosterone used for?FDA label uses
- Is Testosterone a controlled substance?Schedule III
- Generic for NatestoFDA Orange Book
- Generic for AndrogelFDA Orange Book
- Generic for FortestaFDA Orange Book
- Generic for VogelxoFDA Orange Book
- Generic for AxironFDA Orange Book
- Androgens listFDA drug class
- NDC 66887-001Testim NDC record
- Schedule III drugs listDEA schedule